Drug intelligence / Profile preview

NEMO-103

Development stage
Unknown
Lead developer
Inventera
Modality
Nanoparticles → Drug Delivery Systems
Administration
Intraarticular
01

Overview

NEMO-103 is an iron-based, T1-positive contrast agent developed by Inventera for use in direct magnetic resonance (MR) arthrography of the shoulder. The agent consists of a biocompatible dextran core with a supramolecular amorphous iron oxide shell, resulting in a molecular weight of approximately 32 kDa. It is designed to provide superior diagnostic imaging quality for shoulder joint pathologies, including rotator cuff tears and labral tears, by offering a longer joint cavity residence time (greater than 2 hours) compared to conventional gadolinium-based agents. NEMO-103 is intended as a safer alternative to 'off-label' intra-articular gadolinium, which has raised concerns regarding potential joint tissue toxicity.

Other names
NEMO-103 InjectionNEMO103 InjectionNEMO 103 InjectionNEMO-103 Inj.NEMO103 Inj.NEMO 103 Inj.

Beyond the preview

Go deeper on NEMO-103.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NEMO-103.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call